Sino Biopharmaceutical (1177.HK) - The Business, The Concerns, The Insights on Biopharma Valuation
This article analyzed Sino Biopharmaceutical in terms of the business performance, short-term catalyst, concerns about the outlook, and insights on the valuation system of biopharmaceutical companies.